Prostatic specific acid phosphatase
Jump to navigation
Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Prostatic specific acid phosphatase, abbreviated PSAP, is prostate marker that predated prostate-specific antigen (PSA).
It is also known as prostatic acid phosphatase, abbreviated PAP.
General
- Cannot differentiate between benign prostate and prostate cancer, like PSA.[1]
Positive
- Benign prostate.
- Prostate cancer.
- Some hindgut neuroendocrine tumours.[2][3]
Microscopic
Features:
- Cytoplasmic staining.
Images
References
- ↑ Sauvageot, J.; Epstein, JI. (Jan 1998). "Immunoreactivity for prostate-specific antigen and prostatic acid phosphatase in adenocarcinoma of the prostate: relation to progression following radical prostatectomy.". Prostate 34 (1): 29-33. PMID 9428385.
- ↑ Azumi, N.; Traweek, ST.; Battifora, H. (Aug 1991). "Prostatic acid phosphatase in carcinoid tumors. Immunohistochemical and immunoblot studies.". Am J Surg Pathol 15 (8): 785-90. PMID 1712549.
- ↑ Koo J, Zhou X, Moschiano E, De Peralta-Venturina M, Mertens RB, Dhall D (December 2013). "The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin". Endocr Pathol 24 (4): 184–90. doi:10.1007/s12022-013-9264-9. PMID 24037217.